Put Options

24 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $28.4 Million - $32.3 Million
177,400 Added 232.2%
253,800 $46.2 Million
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $23.3 Million - $26.3 Million
-169,600 Reduced 68.94%
76,400 $11.8 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $21.7 Million - $25.1 Million
162,200 Added 193.56%
246,000 $36.7 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $18.3 Million - $22.7 Million
-137,800 Reduced 62.18%
83,800 $11.3 Million
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $9.93 Million - $11.4 Million
68,700 Added 44.93%
221,600 $35.3 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $235,127 - $281,979
1,700 Added 1.12%
152,900 $24.7 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $1.93 Million - $2.22 Million
14,400 Added 10.53%
151,200 $20.3 Million
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $12.4 Million - $15.7 Million
90,000 Added 192.31%
136,800 $21 Million
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $5.91 Million - $7.34 Million
44,800 Added 2240.0%
46,800 $7.59 Million
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $4.09 Million - $5.18 Million
-38,100 Reduced 95.01%
2,000 $271,000
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $542,640 - $615,978
5,100 Added 14.57%
40,100 $4.33 Million
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $694,386 - $773,586
-6,600 Reduced 15.87%
35,000 $3.94 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $2.21 Million - $2.99 Million
27,500 Added 195.04%
41,600 $4.46 Million
Q3 2020

Nov 16, 2020

SELL
$85.91 - $100.83 $352,231 - $413,403
-4,100 Reduced 22.53%
14,100 $1.24 Million
Q2 2020

Sep 10, 2020

SELL
$73.37 - $98.18 $719,026 - $962,164
-9,800 Reduced 35.0%
18,200 $1.79 Million
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $12.4 Million - $18.7 Million
-191,500 Reduced 87.24%
28,000 $2.13 Million
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $1.8 Million - $2.26 Million
25,000 Added 12.85%
219,500 $19.4 Million
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $11.9 Million - $15.1 Million
180,400 Added 1279.43%
194,500 $14.1 Million
Q1 2019

May 15, 2019

SELL
$77.14 - $90.79 $5 Million - $5.88 Million
-64,800 Reduced 82.13%
14,100 $1.14 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $5.66 Million - $6.98 Million
-72,700 Reduced 47.96%
78,900 $7.27 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $7.29 Million - $8.1 Million
-82,000 Reduced 35.1%
151,600 $14.3 Million
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $14.2 Million - $16.8 Million
-158,000 Reduced 40.35%
233,600 $21.6 Million
Q1 2018

May 15, 2018

BUY
$92.01 - $123.21 $35.6 Million - $47.7 Million
387,300 Added 9006.98%
391,600 $37.1 Million
Q4 2017

Feb 14, 2018

BUY
$89.56 - $98.21 $385,108 - $422,303
4,300
4,300 $416,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $303B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.